F Colpaert Selected Research

dexefaroxan

12/2004	In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.
1/2002	Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Colpaert Research Topics

Disease

3	Schizophrenia (Dementia Praecox) 05/2007 - 05/2007
2	Serotonin Syndrome (Syndrome, Serotonin) 05/2007 - 05/2007
2	Catalepsy 05/2007 - 05/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2004 - 01/2002
1	Pain (Aches) 01/2018
1	Acute Pain 01/2018
1	Nociceptive Pain 01/2018
1	Amnesia (Dissociative Amnesia) 05/2007
1	Alzheimer Disease (Alzheimer's Disease) 01/2002
1	Atrophy 01/2002
1	Retrograde Degeneration 01/2002
1	Melanoma (Melanoma, Malignant) 12/2000
1	Experimental Melanoma 12/2000

Drug/Important Bio-Agent (IBA)

3	N- ((2,2- dimethyl- 2,3- dihydrobenzofuran- 7- yloxy)ethyl)- 3- (cyclopent- 1- enyl)benzylamineIBA 05/2007 - 05/2007
3	Cholinergic Agents (Cholinergics)IBA 05/2007 - 01/2002
2	5-HT1A Serotonin ReceptorIBA 05/2007 - 05/2007
2	Antipsychotic Agents (Antipsychotics)IBA 05/2007 - 05/2007
2	dexefaroxanIBA 12/2004 - 01/2002
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	befiradolIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 05/2007
1	Scopolamine (Hyoscine)FDA Link 05/2007
1	Nerve Growth Factor (NGF)IBA 12/2004
1	Pharmaceutical PreparationsIBA 01/2002
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2002
1	Etoposide (VP 16)FDA LinkGeneric 12/2000
1	tafluposideIBA 12/2000

Therapy/Procedure

1	Analgesia 01/2018